fortressbio1.jpg
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 15, 2024 16:15 ET | Fortress Biotech, Inc.
Fortress‘ late-stage pipeline continues to advance and may generate up to three regulatory approvals on NDAs and BLAs in the next 12 months and potentially a fourth BLA filing as early as 2025 FDA...
INVO_Bioscience_Logo.jpg
INVO Reports Record First Quarter 2024 Financial Results
May 15, 2024 16:15 ET | INVO Bioscience
SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...
Agile_Logo-color on white.jpg
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15, 2024 16:10 ET | Agile Therapeutics, Inc.
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15,...
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
May 15, 2024 16:05 ET | Athira Pharma, Inc.
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
neurometrix_rgb.jpg
NeuroMetrix Reports Q1 2024 Business Highlights
May 15, 2024 16:00 ET | NeuroMetrix, Inc.
NeuroMetrix, Inc. today reported financial and business highlights for the quarter ended March 31, 2024.
Dragonfly Energy Logo - Black_PNG.png
CORRECTION – Dragonfly Energy Reports First Quarter 2024 Financial and Operational Results
May 15, 2024 07:30 ET | Dragonfly Energy Holdings Corp.
Please see the updated press release below, which includes previously omitted tables reconciling non-GAAP financial measures. Dragonfly Energy has continued its expansion into the trucking...
NEW ATAI-Logo_Primary.png
atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates
May 15, 2024 06:59 ET | atai Life Sciences
First participant dosed in Phase 1b trial of VLS-01 with data expected in 2H’24; Phase 2 study in TRD patients anticipated to initiate around YE’24Beckley Psytech’s Phase 2a study of BPL-003 in TRD...
Katapult_wSM_Color_RGB_web.png
Katapult Grows First Quarter Revenue 18% Year-Over-Year
May 15, 2024 06:00 ET | Katapult Holdings, Inc.
Katapult reports strong Q1 2024 financial resuilts
A91rwy24l_1p300ls_gm4.png
Lowell Farms Inc. Announces Unaudited First Quarter 2024 Financial and Operational Results
May 14, 2024 17:00 ET | Lowell Farms Inc.
SALINAS, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California cannabis company with advanced distribution and production capabilities...
HEALWELL-AI logo.png
HEALWELL AI Reports Q1-2024 Financial Results
May 14, 2024 16:43 ET | HEALWELL AI Inc.
HEALWELL AI Reports Q1-2024 Financial Result